Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and NINR may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at USA.gov.

 

December 11, 2017

photo of Dr. HeitkemperOn November 14, Dr. Margaret Heitkemper presented the fourth 2017 NINR Director’s Lecture on the NIH Campus in Bethesda, Maryland. In her presentation, “Symptom Science in Irritable Bowel Syndrome: Biomarkers to Intervention," Dr. Heitkemper described her program of research which addresses the pathophysiology and biobehavioral treatment of irritable bowel syndrome (IBS) and the interaction of stress and symptoms in children and adults.

About the Speaker:

Margaret McLean Heitkemper, PhD, RN, FAAN, is Professor and Chairperson, Department of Biobehavioral Nursing and Health Informatics, Adjunct Professor, Division of Gastroenterology, and Co-Director, Center for Innovations in Sleep Self-Management at the University of Washington. Her current studies are examining blood and fecal metabolite levels, the microbiome, and intestinal permeability in men and women with IBS as well as peripheral markers of inflammation.

Video of the lecture is now available. Please click play on the embedded video below or watch on the NINR YouTube channel.

 

About the Event:

The NINR Director’s Lecture series is designed to bring the nation’s top nurse scientists to the NIH campus to share their work and interests with a transdisciplinary audience. Please visit www.ninr.nih.gov/directorslecture for more information.


Share this article on:
Facebook Twitter linkedin Pintrest Google +
Categories: